A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
for Advanced Biliary Tract Cancer
Sites in Minneapolis +17 more locations
Sponsor: J-Pharma Co., Ltd.
Sex: All·Age: 18+
Code: NCT07265674·Phase 3·Recruiting·Listed Dec 2025